Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates

We tested the hypothesis that the use of supplemental oxygen (sO 2 ) at discharge from the NICU in extremely preterm neonates is associated with a greater risk of neurodevelopmental impairment (NDI) at 18 months corrected gestational age (CGA) than the risk of NDI of those neonates discharged in roo...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pediatrics 2013-09, Vol.172 (9), p.1173-1180
Main Authors: Trittmann, J. K., Nelin, L. D., Klebanoff, M. A.
Format: Article
Language:English
Subjects:
Birth weight
Bronchopulmonary Dysplasia - complications
Bronchopulmonary Dysplasia - diagnosis
Bronchopulmonary Dysplasia - therapy
Cerebral Palsy - diagnosis
Cerebral Palsy - epidemiology
Cerebral Palsy - etiology
Childrens health
Communication
Developmental Disabilities - diagnosis
Developmental Disabilities - epidemiology
Developmental Disabilities - etiology
Follow-Up Studies
Gestational age
Hemorrhage
Hospitals
Humans
Hypotheses
Infant
Infant, Extremely Premature
Infant, Newborn
Lung diseases
Medicine
Medicine & Public Health
Menstruation
Original
Original Article
Oxygen Inhalation Therapy - statistics & numerical data
Oxygen Inhalation Therapy - utilization
Patient Discharge
Pediatrics
Premature babies
Prognosis
Regression analysis
Respiration, Artificial
Retrospective Studies
Risk Factors
Severity of Illness Index
Ventilation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We tested the hypothesis that the use of supplemental oxygen (sO 2 ) at discharge from the NICU in extremely preterm neonates is associated with a greater risk of neurodevelopmental impairment (NDI) at 18 months corrected gestational age (CGA) than the risk of NDI of those neonates discharged in room air. Four hundred twenty-four charts were retrospectively reviewed from infants born at 43 weeks PMA.
ISSN:0340-6199
1432-1076
DOI:10.1007/s00431-013-2016-5